Shares of Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) have received an average rating of “Moderate Buy” from the seven ratings firms that are covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and five have issued a buy recommendation on […]
Veracyte, Inc (NASDAQ:VCYT) Receives $30 20 Consensus Target Price from Analysts etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
Champlain Investment Partners LLC lifted its position in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 0.2% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,922,345 shares of the biotechnology company’s stock after purchasing an additional 3,615 shares during the […]
Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) has been given a consensus rating of “Moderate Buy” by the seven brokerages that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and five have assigned a buy recommendation to the […]
Veracyte (NASDAQ:VCYT – Free Report) had its price objective lowered by Needham & Company LLC from $35.00 to $30.00 in a report published on Wednesday, Benzinga reports. The firm currently has a buy rating on the biotechnology company’s stock. Other equities research analysts have also issued research reports about the company. Stephens reiterated an overweight […]